| abstract |
REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING: (I) A NON-PEPTIDE PHARMACEUTICALLY ACTIVE INGREDIENT THAT HAS A SELECTED PRIMARY OR SECONDARY AMINO GROUP OF 1- [5- (2-FLUOROPHENYL) -1- (PYRIDIN-3-ILSUFONIL) -1 -PYRROL-3-IL] -N-METHYLMETHANAMINE; N-METHYL-1- [5- (2-METHYLPHENYL) -1- (PYRIDIN-3-ILSULFONIL) -1H-PYRROL-3-IL] METHANAMINE; OR 1- [4-FLUORO-5- (2-FLUOROPYRIDIN-3-IL) -1- (PYRIDIN-3-ILSULFONYL) -1H-PYRROL-3-IL] -N-METHYLMETHANAMINE OR SALTS THEREOF, WITH A CONTENT OF 0.39 - 26.72% IN THE COMPOSITION; (II) A SELECTED EXCIPIENT OF MANNITOL, CROSCARMELOSE SODIUM, HYDROXYPROPYL CELLULOSE, POLYETHYLENE GLYCOL, AMONG OTHERS, WITH A CONTENT OF 63.28 - 99.35% IN THE COMPOSITION; AND (III) AN ACIDIC COMPOUND AS A STABILIZER SUCH AS FUMARIC ACID, WITH A CONTENT OF 0.05 - 10% IN THE COMPOSITION |